HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Daniel Zips Selected Research

Proton Therapy

8/2015Identification of Patient Benefit From Proton Therapy for Advanced Head and Neck Cancer Patients Based on Individual and Subgroup Normal Tissue Complication Probability Analysis.
1/2015NTCP reduction for advanced head and neck cancer patients using proton therapy for complete or sequential boost treatment versus photon therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Daniel Zips Research Topics

Disease

73Neoplasms (Cancer)
02/2022 - 01/2002
37Squamous Cell Carcinoma of Head and Neck
06/2022 - 01/2010
35Hypoxia (Hypoxemia)
01/2022 - 06/2004
27Prostatic Neoplasms (Prostate Cancer)
04/2022 - 12/2007
21Head and Neck Neoplasms (Head and Neck Cancer)
01/2022 - 10/2012
20Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2017 - 02/2002
11Rectal Neoplasms (Rectal Cancer)
04/2022 - 01/2016
11Neoplasm Metastasis (Metastasis)
04/2022 - 10/2014
9Glioblastoma (Glioblastoma Multiforme)
01/2022 - 10/2005
9Hyperthermia
03/2021 - 07/2015
5Sarcoma (Soft Tissue Sarcoma)
11/2021 - 01/2018
5Carcinoma (Carcinomatosis)
04/2021 - 12/2014
4Lymphatic Metastasis
02/2019 - 05/2011
4Body Weight (Weight, Body)
12/2014 - 03/2005
3Brain Neoplasms (Brain Tumor)
01/2022 - 03/2016
3Breast Neoplasms (Breast Cancer)
09/2021 - 01/2021
3Meningioma (Meningiomas)
06/2021 - 12/2019
3Melanoma (Melanoma, Malignant)
01/2019 - 10/2014
3Lung Neoplasms (Lung Cancer)
02/2018 - 08/2004
2Infections
02/2022 - 12/2018
2Disease Progression
01/2022 - 03/2021
2Fatigue
09/2021 - 04/2021
2Inflammation (Inflammations)
01/2021 - 12/2018
2Glioma (Gliomas)
01/2020 - 09/2015
2Squamous Cell Neoplasms (Squamous Cell Cancer)
03/2019 - 10/2013
2Deglutition Disorders (Dysphagia)
10/2018 - 01/2015
2Necrosis
01/2017 - 06/2005
2Rhabdomyosarcoma
01/2017 - 11/2016
1Alcoholism (Alcohol Abuse)
10/2021
1Chronic Disease (Chronic Diseases)
09/2021
1Triple Negative Breast Neoplasms
09/2020
1Gynecomastia
07/2020

Drug/Important Bio-Agent (IBA)

20fluoromisonidazoleIBA
01/2022 - 10/2012
14Biomarkers (Surrogate Marker)IBA
01/2022 - 11/2006
12DNA (Deoxyribonucleic Acid)IBA
01/2022 - 12/2014
10pimonidazoleIBA
11/2012 - 08/2005
7Proteins (Proteins, Gene)FDA Link
02/2022 - 01/2016
6Messenger RNA (mRNA)IBA
01/2022 - 09/2015
6Cisplatin (Platino)FDA LinkGeneric
04/2021 - 12/2014
6Biological ProductsIBA
01/2021 - 12/2007
5Pharmaceutical PreparationsIBA
10/2021 - 03/2005
4AndrogensIBA
01/2022 - 01/2018
4Oxygen (Dioxygen)IBA
10/2021 - 10/2013
4Glucose (Dextrose)FDA LinkGeneric
01/2021 - 11/2006
4Phosphotransferases (Kinase)IBA
08/2017 - 03/2005
4Lactic Acid (Lactate)FDA LinkGeneric
07/2010 - 11/2006
3Adenosine Triphosphate (ATP)IBA
01/2021 - 11/2006
3Fura-2 (Fura 2)IBA
01/2020 - 03/2016
3CytokinesIBA
04/2018 - 01/2017
3bisbenzimide ethoxide trihydrochloride (Hoechst 33342)IBA
11/2012 - 09/2009
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2012 - 03/2005
3Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
06/2005 - 09/2003
3vatalanib (PTK787)IBA
06/2005 - 09/2003
2Prostate-Specific Antigen (Semenogelase)IBA
04/2022 - 12/2020
2Hormones (Hormone)IBA
01/2022 - 01/2021
2AntigensIBA
01/2022 - 11/2012
2Fluorouracil (Carac)FDA LinkGeneric
11/2021 - 01/2021
2Temozolomide (Temodar)FDA LinkGeneric
01/2020 - 01/2017
2Complement System Proteins (Complement)IBA
09/2019 - 12/2018
2Immune Checkpoint InhibitorsIBA
01/2019 - 01/2018
2Radiation-Sensitizing AgentsIBA
09/2015 - 05/2007
2Protons (Proton)IBA
01/2015 - 11/2006
2NitroimidazolesIBA
01/2015 - 06/2004
2AfatinibIBA
12/2014 - 05/2007
2Cetuximab (Erbitux)FDA Link
02/2014 - 01/2013
2Plasminogen Activator Inhibitor 1IBA
11/2012 - 03/2008
2Pyruvic Acid (Pyruvate)IBA
01/2010 - 11/2006
2Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
05/2007 - 06/2005
2Tyrosine Kinase InhibitorsIBA
05/2007 - 03/2005
2Tyrosine (L-Tyrosine)FDA Link
06/2005 - 03/2005
1HMGB1 Protein (HMG1)IBA
02/2022
1NestinIBA
01/2022
1Gallium-68IBA
01/2022
1Ribosomal Protein S6 Kinases (S6 Kinase)IBA
11/2021
1Aldehyde DehydrogenaseIBA
10/2021
1Disulfiram (Antabuse)FDA Link
10/2021
1IonsIBA
10/2021
1Oncogene Proteins (Oncogene Protein)IBA
10/2021
1Somatostatin Receptors (Somatostatin Receptor)IBA
06/2021
11,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA
01/2021
1Serine (L-Serine)FDA Link
09/2020

Therapy/Procedure

75Radiotherapy
06/2022 - 06/2004
44Chemoradiotherapy
02/2022 - 10/2012
33Therapeutics
02/2022 - 07/2010
14Drug Therapy (Chemotherapy)
06/2022 - 07/2010
6Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
06/2021 - 01/2013
6Immunotherapy
01/2019 - 01/2017
4Image-Guided Radiotherapy
04/2022 - 07/2015
3Particle Accelerators
09/2021 - 01/2021
3Neoadjuvant Therapy
03/2021 - 05/2011
2Castration
04/2022 - 01/2022
2Prostatectomy (Retropubic Prostatectomy)
03/2021 - 01/2018
2Gastrostomy
12/2018 - 10/2018
2Radioimmunotherapy
04/2018 - 02/2014
2Brachytherapy
11/2016 - 12/2007
2Proton Therapy
08/2015 - 01/2015
1Lymph Node Excision (Lymph Node Dissection)
01/2022
1Fitness Trackers
09/2021
1Aftercare (After-Treatment)
09/2021
1Off-Label Use
07/2020